Providing value-driven pharmaceuticals in healthcare

Jasmine Pwu, speaking at Market Access World USA 2011

Jasmine Pwu,
Director of the Health Technology Assessment Division
Center for Drug Evaluation

Dr. Pwu obtained her PhD from College of Public Health, National Taiwan University: and the subject of her dissertation was the application of cost-effective analysis using examples from vaccine and anti-viral treatments.

Initially trained as an epidemiologist, Dr. Pwu has been an expert in both research design and execution and large database analysis. She later became interested in economic evaluations, especially modelling studies. In this area, she has nearly 20 years of research experience.

Dr. Pwu is currently Director of the Health Technology Assessment Division for the Center for Drug Evaluation in Taiwan. Her division (CDE/HTA) works closely with the Bureau of National Health Insurance for reimbursement and pricing decisions. Her experiences has led to her participation in several research projects designed to aid health policy decision-making in areas such as anti-HBV treatment, cervical cancer screening and HPV vaccination. Prior to CDE, she worked as a consultant, for both government and industry, conducting economic evaluation studies.

Dr. Pwu is also an adjunct Assistant Professor at the Taipei Medical University.

Appearing:

Day Two Thursday 6th October 2011

12pm

A perspective from Taiwan on HTA assessments

Healthcare in Taiwan - compulsory national health insurance and National Health Insurance (NHI)
Rules of pricing and reimbursement and its relationship with HTA assessments
Future planning for second-generation NHI Act

Jasmine Pwu,

Director of the Health Technology Assessment Division,
Center for Drug Evaluation

Sponsor Market Access World USA 2011 ›

Session Facilitator